Seeing White Matter Aging Through the Visual System
Dr. Janos Groh from the Technical University of Munich explores how the visual system can be used to uncover the cellular, molecular, and neuroinflammatory mechanisms driving white matter aging.
Uniting biology and digital drug discovery to identify new therapeutic opportunities in neurodegeneration
As the FDA and NIH encourage a shift away from animal testing, there’s growing momentum behind New Approach Methodologies (NAMs) — from advanced in vitro models to computational platforms. In this webinar, Concept Life Sciences and Delta4 present a powerful example of what this future looks like in practice.
Exploring the iPSC-Derived Neuronal-Glia Co-culture System: A Powerful Drug Discovery Platform for Studying Neurodegenerative Diseases
Learn how FUJIFILM’s iPSC-derived neuron-glia co-culture system supports drug discovery and disease modeling for neurodegenerative disorders.
Clearing the Brain Fog: Long COVID and Cognitive Impairment
One common post-COVID symptom is brain fog or "COVID fog," which may affect up to 25% of recovered individuals. Given the global prevalence of SARS-CoV-2 and the detrimental impact of such cognitive impairment, the public health implications are considerable. Fernández-Castañeda et al. recently examined the underlying neurological changes associated with COVID fog, which we review in this blog post.
Video Game Therapy: A “Game Changer” for Post-COVID Brain Fog
Originally posted on Scientist.com, this article takes a look at post-COVID brain fog, its causes, and video game therapy as a potential treatment.
Assessing Neuroinflammation-Related Neural Damage by Monitoring the Retinotectal System
Dr. Janos Groh discusses how neuroinflammation amplifies neural damage and disease outcome in models of various disorders, and the value of monitoring the retinotectal system to assess neural disease progression and associated treatment efficacy.
